Type 1 diabetes (T1D) and multiple sclerosis
Type 1 diabetes (T1D) and multiple sclerosis
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
Identification of common key genes and pathways between type 1 diabetes and multiple sclerosis using transcriptome and interactome analysis.
https://www.ncbi.nlm.nih.gov/pubmed/31912409
Abstract
PURPOSE:
Type 1 diabetes (T1D) and multiple sclerosis (MS) are classified as T cell-mediated autoimmune diseases. Although convergent evidence proposed common genetic architecture for autoimmune diseases, it remains a challenge to identify them. This study aimed to determine common gene signature and pathways in T1D and MS via systems biology approach.
METHODS:
Gene expression profiles of peripheral blood mononuclear cells (PBMCs) and pancreatic-β cells in T1D as well as PBMCs and cerebrospinal fluid (CSF) in MS were analyzed in our previous published data, and differential expressed genes were integrated with protein-protein interactions data to construct Query-Query PPI (QQPPI) networks. In this study, QQPPI networks were further analyzed to investigate more central genes, functional modules and complexes shared in T1D and MS progression. Lastly, the interaction of common genes with drugs was also explored.
RESULTS:
Several cytokines such as IL-23A, IL-32, IL-34, and IL-37 tend to be differentially expressed in both diseases. In addition, PSMA1, MYC, SRPK1, YBX1, HNRNPM, NF-κB2, IKBKE, RAC1, FN1, ARRB2, ESR1, HSP90AB1, and PPP1CA were common high central genes in QQPPI networks corresponding to each disease. Proteasome, spliceosome, immune responses, apoptosis, cellular communication/signaling transduction mechanism, interaction with environment, and activity of intercellular mediators were shared biological processes in T1D and MS. Finally, azathioprine, melatonin, resveratrol, and geldanamycin identified as prioritized drugs for the treatment of patients with T1D and MS.
CONCLUSIONS:
This study represented novel key genes and pathways shared between T1D and MS, which may facilitate the identification of potential therapeutic targets in these diseases.
Re: Type 1 diabetes (T1D) and multiple sclerosis
-
- Similar Topics
- Replies
- Views
- Last post
-
-
Relationship between MS and type-1 diabetes
by frodo » Mon Jan 13, 2020 12:52 am » in MS Etiology and Pathogenesis - 2 Replies
- 650 Views
-
Last post by frodo
Mon Jan 20, 2020 4:25 am
-
-
- 0 Replies
- 2693 Views
-
Last post by NHE
Fri Mar 22, 2019 11:31 pm
-
-
type-1 diabetes and MS. New kind of cells discovered.
by frodo » Fri Nov 06, 2020 5:09 am » in MS Etiology and Pathogenesis - 0 Replies
- 196 Views
-
Last post by frodo
Fri Nov 06, 2020 5:09 am
-
-
- 1 Replies
- 893 Views
-
Last post by Petr75
Sat Nov 02, 2019 9:51 am
-
- 3 Replies
- 1725 Views
-
Last post by Petr75
Thu Mar 05, 2020 9:23 am
-
- 4 Replies
- 1680 Views
-
Last post by zen2010
Mon Feb 25, 2019 9:52 am
-
- 0 Replies
- 299 Views
-
Last post by Petr75
Sun Oct 18, 2020 6:20 am
-
-
Biomarker: N-glucosylation in Multiple Sclerosis
by frodo » Tue Jul 21, 2020 1:54 am » in MS Etiology and Pathogenesis - 0 Replies
- 219 Views
-
Last post by frodo
Tue Jul 21, 2020 1:54 am
-
-
- 0 Replies
- 438 Views
-
Last post by Petr75
Thu Mar 19, 2020 10:24 am